New approach to multiple sclerosis research hopes to find more effective treatments, cure

October 10, 2005

A new university-public research partnership will help physicians and researchers work toward a better understanding of multiple sclerosis (MS), the development of novel treatments and ultimately the goal of finding a cure. The Oak Clinic/Kent State University Consortium for Multiple Sclerosis and Neurodegenerative Disease Research combines the clinical expertise of physicians dedicated to the diagnosis and treatment of MS patients with substantial expertise in basic neuroscience research by Kent State biomedical researchers.

MS is a chronic, potentially disabling disease that affects the central nervous system and typically strikes individuals during their early adult years. The disease can be especially devastating due to the profound disability associated with its progression and its economic impact, since MS persists through what is often a normal lifespan.

The interdisciplinary research group at Kent State is using advanced molecular techniques and three-dimensional imaging to visualize the basic mechanisms of MS, which have yet to be clearly understood. The consortium's use of advanced imaging techniques will provide a great deal more information to clinicians and scientists than is currently available through the use of two-dimensional images. Early diagnosis techniques and more effective treatments may potentially result. This technology also will be used to better track the effectiveness of current and future therapies.

Use of high-resolution, three-dimensional magnetic resonance imaging of the central nervous system is just one component of the consortium's efforts. Consortium scientists also are investigating a new hypothesis endorsed by the National Institutes of Health--that the destruction of nerves which underlies MS begins with changes to the internal machinery inside a cell rather than to destruction of the covering that normal nerve cells have. The Kent State approach complements standard MS research programs, in which the autoimmune process thought to be responsible for demyelination, or the destruction of the protective sheath surrounding nerve fibers, is the focus of study.
-end-


Kent State University

Related Multiple Sclerosis Articles from Brightsurf:

New therapy improves treatment for multiple sclerosis
A new therapy that binds a cytokine to a blood protein shows potential in treating multiple sclerosis, and may even prevent it.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

New therapeutic options for multiple sclerosis in sight
Strategies for treating multiple sclerosis have so far focused primarily on T and B cells.

Diet has an impact on the multiple sclerosis disease course
The short-chain fatty acid propionic acid influences the intestine-mediated immune regulation in people with multiple sclerosis (MS).

The gut may be involved in the development of multiple sclerosis
It is incompletely understood which factors in patients with multiple sclerosis act as a trigger for the immune system to attack the brain and spinal cord.

Slowing the progression of multiple sclerosis
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown.

7T MRI offers new insights into multiple sclerosis
Investigators from Brigham and Women's Hospital have completed a new study using 7 Tesla (7T) MRI -- a far more powerful imaging technology -- to further examine LME in MS patients

How to improve multiple sclerosis therapy
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase.

Vaccinations not a risk factor for multiple sclerosis
Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich (TUM) which investigated the population's vaccination behavior in relation to MS.

Read More: Multiple Sclerosis News and Multiple Sclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.